FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

COO

Cooper Companies (The)NASDAQ · Health Care Supplies · Health Care
Previous close
59.55
Change
−0.79 / −1.31%
FinDog View
Neutral
52-Week Range ?
51.01 – 89.83
P/E (TTM) ?
20.0
Forward P/E ?
11.8
Based on consensus earnings for the next 12 months
Market Cap
$11.3B
1M
+5.34%
S&P 500 −0.91% over same period
Volume / Avg Volume
7.9M / 2.5M
3.20× average
Latest earnings analysisFY2026 Q3Reported 2026-09-09

CooperCompanies Q3 FY2026: revenue up 1.0%, GAAP EPS $2.24 on tax benefit

CooperCompanies grew revenue just 1.0% to $1.066 billion and its headline GAAP profit was inflated by a one-time $307.2 million U.K. tax benefit, while non-GAAP EPS rose 4.0% to $1.15. Guidance for the fourth quarter sits roughly flat versus this quarter and below the consensus next-quarter figure of $1.079 billion, so the read-through is steady cash generation, muted top-line momentum.

Read the full analysis →
Revenue$1.07BYoY +0.60%
EPS (non-GAAP)$1.15
Next-quarter revenue guidance$1.07B ±1.1%Below estimatesest. $1.08B
Next-day move−14.67%

Price History

Closing price · USD1M6M1Y5Y
54565860622026-092026-102026-102026-102026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 45.91M6M1Y5Y
0204060802023-122024-092025-052026-022026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2026-12-02
in 30 days · After hours
Consensus EPS
$1.08
Last quarter EPS $1.15
Avg. next-day move over the last 6 reports
±10.2%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 4 of its 5-year rangeCheap
5-year range 29.6 – 65.8 · Median 45.9
Last 4 quarters: $644M in buybacks + $0 in dividends, 5.69% of market cap combined
P/E (TTM)
20.0
P/B
1.4
P/S
2.7
Dividend Yield
0.02%
Earnings Reaction
Over the last 6 reports, the stock moved ±10.2% on average on the first trading day after, rising 2 times
Most recent −14.67%
Volatility & Correlation
1-year beta 0.44 · Correlation with S&P 500 0.18Low beta
Annualized volatility 32% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 5 · $1.9MSell 0 · $0.00MNet buying $1.9M
  • 09-16Kurzius Lawrence ErikDirectorBuy$0.55M10,000 shares · Avg price 54.93
  • 09-14Kurzius Lawrence ErikDirectorBuy$0.54M10,000 shares · Avg price 53.92
  • 09-14Rosebrough Walter M JrDirectorBuy$0.16M3,000 shares · Avg price 54.29
  • 09-11Keel Paul ADirectorBuy$0.25M4,701.015 shares · Avg price 53.18
  • 09-11Rosebrough Walter M JrDirectorBuy$0.38M7,000 shares · Avg price 54.11
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q31.07+0.6%66.8%0.220.430.272.24
FY2026 Q21.08+7.9%68.0%-0.03-0.080.10-0.40
FY2026 Q11.02+6.2%67.9%0.210.130.160.66
FY2025 Q41.07+4.6%61.1%0.140.080.150.42
FY2025 Q31.06+5.7%65.3%0.180.100.160.49
FY2025 Q21.00+6.3%67.8%0.180.090.020.44
FY2025 Q10.96+3.6%68.4%0.180.100.100.52
FY2024 Q41.02+9.8%66.5%0.200.120.130.59
FY2024 Q31.00+7.8%66.1%0.190.100.120.52
FY2024 Q20.94+7.4%67.0%0.160.090.040.44
FY2024 Q10.93+8.5%67.0%0.150.080.000.41
FY2023 Q40.93+9.3%65.4%0.140.080.030.42

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView